Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-22-015960

EVP, Chief Medical Officer sold 1,051 shares at $112.24 ($117,964)

  • EVP, Chief Medical Officer acquired 13,816 shares (grant or award)
  • EVP, Chief Medical Officer acquired 3,187 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lebwohl David EVP, Chief Medical Officer 2022-01-01 Option exercise +3,187 11,973 D: show line 1 in the form
Lebwohl David EVP, Chief Medical Officer 2022-01-01 Sale −1,051 $112.24 $117,964 10,922 D: show line 2 in the form
Lebwohl David EVP, Chief Medical Officer 2022-03-01 Grant or award +13,816 24,738 D: show line 3 in the form
Open-market sales · 1,051 sh · avg $112.24 · $117,964

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lebwohl David EVP, Chief Medical Officer 2022-01-01 Option exercise · Restricted Stock Unit −3,187 9,563 D: show line 4 in the form
Lebwohl David EVP, Chief Medical Officer 2022-03-01 Grant or award · Stock Option (right to buy) +13,816 13,816 D: show line 5 in the form
Loading xslF345X03/doc4.xml…